Director/PDMR Shareholding

RNS Number : 7148F

Medica Group PLC

08 November 2022

 

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 7 November 2022, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Deferred Bonus Plan 2017 at a nil exercise price:

Name of PDMR	Number of shares subject to option
Stuart Quin		87,409
Richard Jones		61,700
Kevin Terrins		38,181
Sarah Burns		38,181
Marc O'Brien Caroline Byrne Rob Lavis		46,275 21,389 24,722

The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation, and set out more details of the transactions.

1.	Details of PDMR
(a)	Name	1.  Stuart Quin 2.  Richard Jones 3.  Kevin Terrins 4.  Sarah Burns 5.  Marc O'Brien 6.  Caroline Byrne 7.  Rob Lavis
2.	Reason for notification
(b)	Position / status	1.  Chief Executive Officer 2.  Chief Financial Officer 3.  Group Director of Corporate Development 4.  Managing Director, UK 5.  Chief Information Officer 6.  Managing Director, Ireland 7.  Group Medical Director
	Initial notification / amendment	Initial notification in each case
3.	Details of the Issuer
(a)	Name	Medica Group PLC
(b)	LEI	213800B8XE5FUSZF5Z16
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted
(a)	Description of the financial instrument	Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b)	Nature of the transaction	Grant of options to acquire Shares pursuant to the Company's Deferred Bonus Plan 2017
(c)	Price(s) and volume	Option Price nil in each case 1. 87,409 2. 61,700 3. 38,181 4. 38,181 5. 46,275 6.  21,389 7.  24,722
(d)	Aggregated information	N/A
(e)	Date of the transaction	7 November 2022
(f)	Place of the transaction	Outside a trading venue

 

END

 

 

DSHBKFBBNBDDDDK